US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Inc (VRTX) ニュース

VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VRTX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	04 : 32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/20	21 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/20	21 : 25	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/18	05 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/18	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/18	05 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/18	05 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/18	05 : 16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/17	05 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/16	01 : 20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/16	00 : 50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/16	00 : 41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/15	23 : 30	Business Wire	Jennifer Schneider Elected to Vertex Board of Directors	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/10	21 : 01	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/08	21 : 54	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/08	05 : 14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/07	20 : 46	IH Market News	Disney Slashes Streaming Losses, UBS shoots up 9% as profit triples expectations, and More in Earnings	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/07	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/07	05 : 01	Business Wire	Vertex Reports First Quarter 2024 Financial Results	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/06	21 : 09	IH Market News	Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/27	00 : 43	Business Wire	Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/23	13 : 45	PR Newswire (Canada)	VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/23	13 : 45	PR Newswire (US)	VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/23	13 : 45	PR Newswire (US)	VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/18	21 : 00	Business Wire	Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/11	20 : 24	IH Market News	Costco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More News	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/11	05 : 01	Business Wire	Vertex Enters Into Agreement to Acquire Alpine Immune Sciences	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/11	05 : 01	Business Wire	Vertex Enters Into Agreement to Acquire Alpine Immune Sciences	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/10	05 : 05	Business Wire	Vertex to Announce First Quarter 2024 Financial Results on May 6	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/04/02	00 : 00	PR Newswire (Canada)	Vertex Announces New Drug Submission for Exagamglogene Autotemcel (exa-cel) Has Been Accepted for Priority Review by Health Canada for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia	NASDAQ:VRTX	Vertex Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:VRTX

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

Invesco QQQ Trust Series 1

JP Morgan Chase

BNP Paribas (QX)

US Dollar vs Euro

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約